ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
ImmunityBio, Inc.
NASDAQ:IBRXHealthcare · Biotechnology
-5.15%$8.29
AH$8.29+0.00%vs close
Mkt Cap$8.79B
Float395M
O/S1.06B
Vol
$ Vol
RVOL
Inst Own19.1%
SI31.1%
Earnings
Dilution
Financials Summary
Revenue$113.29M
Net Income-$351.4M
Total Assets$501.9M
Free Cash Flow-$308.78M
Debt & Equity
Debt 232%
Total Debt$878.12M
Total Equity-$499.57M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IBRX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$501.9M
Liabilities$1B
Accounts Receivable$42.62M
Accounts Payable$6.98M
Inventory$910K
PP&E (Net)$147.54M
Goodwill$910K
Intangible Assets$13.04M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $113.29M | $14.74M | $622K | $240K | $934K | $605K | $43K | $47K | $45K | $44K | $236K | $641K | $600K |
| YoY Growth | 668.3% | 2270.6% | 159.2% | -74.3% | 54.4% | 1307.0% | -8.5% | 4.4% | 2.3% | -81.4% | -63.2% | 6.8% | - |
| Cost of Revenue | $753K | $0 | $0 | $0 | $0 | $0 | $9.01M | -$3.11M | $0 | $0 | $0 | $0 | $253K |
| Gross Profit | $112.53M | $14.74M | $622K | $240K | $934K | $605K | -$8.97M | $3.16M | $45K | $44K | $236K | $641K | $347K |
| Gross Margin | 99.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -20858.1% | 6717.0% | 100.0% | 100.0% | 100.0% | 100.0% | 57.8% |
| Research and Development | $207.88M | $190.14M | $232.37M | $248.15M | $195.96M | $139.51M | $48.88M | $53.42M | $39.78M | $26.55M | $11.43M | $1.59M | $446K |
| Selling, General, and Administrative | $147.18M | $168.78M | $129.62M | $102.71M | $135.26M | $71.32M | $9.05M | $35.46M | $53.82M | $94.39M | $226.21M | $4.33M | $2.42M |
| Other | $13.51M | $0 | $886K | $681K | $0 | $10.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $368.56M | $358.93M | $362.87M | $351.54M | $331.21M | $221.49M | $57.94M | $88.88M | $93.6M | $120.94M | $237.64M | $5.92M | $2.87M |
| Operating Income (EBIT) | -$256.03M | -$344.18M | -$362.25M | -$351.3M | -$330.28M | -$220.88M | -$66.91M | -$98.39M | -$99.12M | -$124.5M | -$238.88M | -$6.21M | -$2.27M |
| Operating Margin | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -36509.1% | -155597.7% | -209338.3% | -220266.7% | -282954.5% | -101218.6% | -969.1% | -378.2% |
| Interest Expense | $112.53M | $131.66M | $86.72M | $47.15M | $14.85M | $9.07M | $5.92M | $433K | $618K | $66K | $0 | $0 | $463K |
| Interest Income | $6.7M | $2.4M | $863K | $2.71M | $836K | $1.73M | $2.76M | $0 | $0 | $0 | $0 | $0 | $2K |
| Other Income (Expense) | -$95.58M | -$69.46M | -$221.64M | -$65.99M | -$19.56M | -$5.15M | $1.02M | $1.66M | $2.2M | $3.12M | $1.7M | -$609K | $223K |
| Income Before Tax (EBT) | -$351.61M | -$413.64M | -$583.89M | -$417.29M | -$349.84M | -$226.03M | -$65.89M | -$96.73M | -$96.92M | -$121.38M | -$237.18M | -$6.21M | -$2.05M |
| Income Tax Expense | -$135K | $0 | -$40K | $34K | $9K | -$1.85M | -$97K | -$503K | -$493K | -$572K | -$301K | $1K | $1K |
| Net Income | -$351.4M | -$413.56M | -$583.2M | -$416.57M | -$346.79M | -$221.85M | -$65.79M | -$96.23M | -$96.42M | -$120.81M | -$236.88M | -$6.21M | -$2.05M |
| Net Income Margin | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -36669.6% | -152997.7% | -204736.2% | -214273.3% | -274565.9% | -100371.2% | -969.3% | -341.2% |
| Supplementary Data | |||||||||||||
| EPS | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 | -0.59 | -0.42 | -0.30 | -0.30 | -0.37 | -0.73 | -0.02 | -0.01 |
| Diluted EPS | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 | -0.59 | -0.42 | -0.30 | -0.30 | -0.37 | -0.73 | -0.02 | -0.01 |
| Weighted Average OS | 919.86M | 697.31M | 508.64M | 399.90M | 389.23M | 383.18M | 383.18M | 325.05M | 316.15M | 328.55M | 326.30M | 315.73M | 315.73M |
| EBITDA | -$223.56M | -$264.43M | -$478.66M | -$351.88M | -$320.75M | -$204.22M | -$51.83M | -$86.74M | -$90.73M | -$117.71M | -$235.71M | -$5.68M | -$1.58M |
| EBITDA Margin | -197.3% | -1793.4% | -76955.5% | -146617.1% | -34341.8% | -33755.4% | -120523.3% | -184555.3% | -201626.7% | -267518.2% | -99875.0% | -885.6% | -263.2% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $88.33M | $143.43M | $265.45M | $104.64M | $181.1M | $34.91M | $15.51M | $16.82M | $23.87M | $8.08M | $175.91M | $59.1M | $350K |
| Short-Term Investments | $154.48M | $6.38M | $1.01M | $2.54M | $136.01M | $61.15M | $36.14M | $57.33M | $104.28M | $190.84M | $118.31M | $0 | $0 |
| Cash and Short-Term Investments | $242.82M | $149.81M | $266.46M | $107.18M | $317.12M | $96.06M | $51.65M | $74.15M | $128.15M | $198.92M | $294.22M | $59.1M | $350K |
| Accounts Receivable | $42.62M | $2.65M | $3.17M | $1.89M | $1.33M | $2M | $303K | $12.17M | $1.26M | $0 | $1.77M | $145K | $380K |
| Inventory | $910K | $8.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.89M | $1.3M | $5.21M | $2.9M | $2.96M | $0 | $24K | $42K | $880K | $662K | $0 | $0 | $248K |
| Total Current Assets | $314.88M | $184.59M | $294.08M | $140.58M | $334.35M | $111.71M | $55.76M | $88.77M | $132.46M | $205.15M | $297.54M | $59.37M | $978K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $147.54M | $170.46M | $182.68M | $189.45M | $119.17M | $90.68M | $72.23M | $76.89M | $76.73M | $19.27M | $6.15M | $211K | $13K |
| Goodwill | $910K | $910K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $13.04M | $15.02M | $17.09M | $20M | $1.42M | $1.46M | $0 | $12.09M | $2.83M | $5.09M | $7.29M | $835K | $863K |
| Long-Term Investments | $10.48M | $700K | $891K | $840K | $7.6M | $11.4M | $10.93M | $14.38M | $38.28M | $87.75M | $55.13M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$8.5M | $0 | $110K | $391K | $0 | $0 |
| Other Long-Term Assets | $15.04M | $11.26M | $9.7M | $11.49M | $6.38M | $6.13M | $4.21M | -$1.67M | $151K | $137K | $344K | $409K | $249K |
| Total Long-Term Assets | $187.02M | $198.35M | $210.37M | $221.78M | $134.56M | $109.67M | $87.37M | $93.18M | $117.98M | $112.35M | $69.31M | $1.46M | $1.13M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $501.9M | $382.93M | $504.45M | $362.36M | $468.91M | $221.38M | $143.12M | $181.95M | $250.44M | $317.5M | $366.85M | $60.83M | $2.1M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $6.98M | $6.72M | $9.2M | $21.02M | $11.42M | $11.51M | $1.75M | $2.79M | $5.87M | $4.04M | $2.08M | $1.13M | $1.5M |
| Short-Term Debt | $9.29M | $0 | $0 | $431.9M | $299.24M | $0 | $3.96M | $965K | $618K | $534K | -$228K | $265K | $1.76M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $520K | $197K | $228K | $521K | $573K |
| Other Current Liabilities | $25.42M | $15.98M | $18.31M | $19.74M | $16.52M | $18M | $4.78M | $23.5M | $13.87M | $7.78M | $4.06M | -$33K | -$1.19M |
| Total Current Liabilities | $61.75M | $54.94M | $58.28M | $500.86M | $369M | $68.13M | $11.56M | $27.26M | $20.87M | $12.55M | $6.15M | $2.4M | $5M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $835.15M | $461.88M | $681.54M | $241.27M | $306.35M | $254.35M | $0 | $0 | $0 | $0 | $2.47M | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $166K | $187K | $228K | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $162K | $170K | $0 | $0 | $498K | $996K | $1.17M | $0 | $0 |
| Other Long-Term Liabilities | $70.89M | $319.42M | $310.63M | $22.09M | $249K | $1.03M | $0 | $2.74M | $3.41M | $2.67M | -$1.4M | $521K | $2.35M |
| Total Long-Term Liabilities | $939.72M | $816.12M | $1.03B | $311.31M | $343.83M | $271.74M | $10.88M | $8.68M | $10.73M | $11.53M | $4.71M | $1.92M | $3.83M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.92M | -$3.83M |
| Total Liabilities | $1B | $871.06M | $1.09B | $812.18M | $712.82M | $339.87M | $22.44M | $35.94M | $31.6M | $24.08M | $10.85M | $2.4M | $5M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $101K | $85K | $67K | $42K | $40K | $38K | $10K | $8K | $8K | $8K | $8K | $3K | $2K |
| Retained Earnings | -$3.73B | -$3.38B | -$2.96B | -$2.38B | -$1.96B | -$1.62B | -$662.19M | -$594.98M | -$498.71M | -$387.06M | -$250.38M | -$12.74M | -$6.53M |
| Comprehensive Income & Other | $28.96M | $1.2M | $10K | $183K | $4K | $122K | -$105K | -$267K | -$381K | -$284K | -$192K | -$46K | -$9K |
| Other Stockholders' Equity | $3.23B | $2.89B | $2.37B | $1.93B | $1.72B | $1.5B | $782.86M | $740.98M | $717.55M | $680.47M | $606.36M | $71.16M | $3.63M |
| Total Equity | -$499.57M | -$489.1M | -$586.99M | -$447.33M | -$242.17M | -$119.81M | $120.68M | $146.01M | $218.84M | $293.42M | $356M | $58.42M | -$2.9M |
| Minority Interest | $895K | $969K | $1.05M | -$2.49M | -$1.74M | $1.32M | $0 | -$12.32M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $501.9M | $381.96M | $503.4M | $364.85M | $470.65M | $220.06M | $143.12M | $181.95M | $250.44M | $317.5M | $366.85M | $60.83M | $2.1M |
| Supplementary Data | |||||||||||||
| Total Debt | $878.12M | $504.17M | $726.72M | $723.77M | $645.66M | $275.55M | $14.85M | $6.91M | $7.27M | $8.21M | $2.47M | $265K | $1.76M |
| Net Debt | $789.78M | $360.74M | $461.27M | $619.13M | $464.56M | $240.63M | -$660K | -$9.91M | -$16.6M | $127K | -$173.44M | -$58.84M | $1.41M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$351.47M | -$413.64M | -$583.85M | -$416.57M | -$346.79M | -$224.19M | -$160.16M | -$96.23M | -$96.42M | -$120.81M | -$236.88M | -$6.21M | -$2.05M |
| Depreciation & Amortization | $15.53M | $17.55M | $18.51M | $18.26M | $14.24M | $12.74M | $14.04M | $9.55M | $5.57M | $3.61M | $1.47M | $128K | $4K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$2.94M | -$8K | -$498K | -$497K | -$575K | -$302K | $0 | $0 |
| Stock-Based Compensation | $36.81M | $34.43M | $49.16M | $40.18M | $57.18M | $2.19M | $3.42M | $2.04M | $37M | $73.85M | $211.22M | $0 | $0 |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$40.21M | -$2.36M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.46M | $75K | $95K | -$173K |
| Inventory | -$6.33M | -$8.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$190K | -$3.17M | -$6.48M | $0 | $0 | $2.57M | $1.19M | -$1.1M | $150K | $888K | $627K | -$347K | $700K |
| Other Working Capital | -$7.6M | -$5.62M | $10.3M | -$16M | -$15.39M | $13.79M | -$16.82M | $546K | $3.08M | $2.95M | -$420K | $61.24M | $329K |
| Total Working Capital Change | -$54.33M | -$19.42M | $3.83M | -$16M | -$15.39M | $16.36M | -$15.64M | -$554K | $3.23M | $3.84M | $282K | $60.99M | $856K |
| Other Non-Cash Items | $48.53M | -$10.15M | $145.44M | $36.62M | $16.35M | $24.11M | $6.23M | $44.55M | $50.33M | $81.67M | $212.36M | -$61.05M | -$365K |
| Net Cash from Operating | -$304.94M | -$391.24M | -$366.76M | -$337.51M | -$274.42M | -$171.72M | -$152.11M | -$63.38M | -$48.78M | -$38.59M | -$25.3M | -$5.35M | -$668K |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$4.25M | -$6.89M | -$30.58M | -$78.16M | -$33.56M | -$1.67M | -$4.29M | -$13.1M | -$34.81M | -$6.56M | -$2.24M | -$299K | -$3K |
| Acquisitions | $0 | -$1M | $0 | $0 | $0 | $8K | $200K | $412K | -$32K | -$137K | -$1.82M | $0 | $0 |
| Purchases of Investments | -$241.37M | -$140.22M | -$10.36M | $0 | $0 | -$91.77M | -$87.19M | -$95.49M | -$119.86M | -$273M | -$198.07M | $0 | $0 |
| Sales of Investments | $95.82M | $136.61M | $10.47M | $0 | $0 | $73.62M | $112.33M | $165.28M | $254.22M | $165.89M | $26.9M | $0 | $0 |
| Other Investing Activities | $0 | -$747K | $0 | $105.46M | -$51.32M | -$8K | -$2.5M | $35.03M | $32K | $137K | -$1.82M | $0 | $0 |
| Net Cash from Investing | -$149.8M | -$12.25M | -$30.47M | $27.3M | -$84.89M | -$19.81M | $18.55M | $57.1M | $99.55M | -$113.67M | -$175.22M | -$299K | -$3K |
| Financing Activities | |||||||||||||
| Debt Repaid | -$1.72M | -$96.89M | -$451.39M | -$174.07M | -$338.5M | -$63.7M | -$47.67M | $477K | $19.93M | $32K | $132K | $53K | $1K |
| Common Stock Issuance | $400.78M | $111.36M | $110.4M | $0 | $0 | $86.3M | $30M | $57K | $1.22M | $1.43M | $324.68M | $0 | $676K |
| Common Stock Repurchases | $0 | $0 | $0 | -$616K | -$4.06M | $0 | -$2.5M | -$228K | -$15.23M | -$15.85M | -$4.8M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$2.27M | $73.38M | -$3.44M | $60.16M | $171.01M | $673K | $39.11M | -$123K | -$1.04M | -$1.11M | -$2.42M | $0 | $0 |
| Net Cash from Financing | $400.24M | $281.63M | $558.34M | $233.61M | $505.44M | $150.68M | $114.28M | -$771K | -$34.98M | -$15.56M | $317.33M | $64.41M | $905K |
| Forex Effect | $15K | -$23K | -$292K | $284K | $48K | -$25K | -$21K | -$30K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$54.48M | -$121.88M | $160.82M | -$76.31M | $146.19M | -$40.89M | -$19.3M | -$7.05M | $15.79M | -$167.82M | $116.8M | $58.75M | $234K |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$304.94M | -$391.24M | -$366.76M | -$337.51M | -$274.42M | -$171.72M | -$152.11M | -$63.38M | -$48.78M | -$38.59M | -$25.3M | -$5.35M | -$668K |
| Capital Expenditure | -$3.85M | -$6.89M | -$30.58M | -$78.16M | -$33.56M | -$1.67M | -$4.29M | -$13.1M | -$34.81M | -$6.56M | -$2.24M | -$299K | -$3K |
| Free Cash Flow | -$308.78M | -$398.12M | -$397.34M | -$415.67M | -$307.98M | -$173.39M | -$156.4M | -$76.48M | -$83.59M | -$45.15M | -$27.55M | -$5.65M | -$671K |
| Cash at Beginning | $143.91M | $265.79M | $104.97M | $181.28M | $35.09M | $75.98M | $95.28M | $23.87M | $8.08M | $175.91M | $59.1M | $350K | $116K |
| Cash at End | $89.43M | $143.91M | $265.79M | $104.97M | $181.28M | $35.09M | $75.98M | $16.82M | $23.87M | $8.08M | $175.91M | $59.1M | $350K |